Chemical formula: C₂₃H₃₀O₆S Molecular mass: 434.176 g/mol PubChem compound: 11988953
Luseogliflozin is indicated for:
Population group: only adults (18 years old or older)
Luseogliflozin is indicated in the treatment of type 2 diabetes mellitus to improve glycemic control in adults as:
Monotherapy
When diet and exercise alone do not provide adequate glycemic control in patients for whom use of metformin is considered inappropriate due to intolerance.
Add-on combination therapy
In combination with glucose-lowering medicinal products including insulin preparations in adult patients with type 2 diabetes mellitus to improve glycemic control when diet and exercise plus monotherapy does not provide adequate glycemic control.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Luseogliflozin is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.